Interleukin-22: A likely target for treatment of autoimmune diseases

Autoimmunity Reviews

Volumn 13, Issue 6, 2014, Pages 615-620

  Yang, Xuyan ^a   Zheng, Song Guo ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; Cytokine receptor; Innate immunity; Interleukin 22; Signal pathway; T helper cell

Indexed keywords

INTERLEUKIN 22;

ALLERGIC DISEASE; AUTOIMMUNE DISEASE; DOWNSTREAM PROCESSING; GRAFT VERSUS HOST REACTION; HELPER CELL; HEPATITIS; HUMAN; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; TH17 CELL; THERAPY EFFECT; TREATMENT OUTCOME;

AUTOIMMUNITY; CYTOKINE RECEPTOR; INNATE IMMUNITY; INTERLEUKIN-22; SIGNAL PATHWAY; T-HELPER CELL;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; INTERLEUKIN-17; INTERLEUKINS; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84896547798     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2013.11.008     Document Type: Review

References (51)

1. Dumoutier L., Louahed J., Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819. [Pubmed: 10657629].
2. Dumoutier L., Van Roost E., Colau D., Renauld J.C. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci U S A 2000, 97(18):10144-10149. [29, Pubmed: 10954742].
3. Dumoutier L., Van Roost E., Ameye G., Michaux L., Renauld J.C. IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes. Genes Immun 2000, 1(8):488-494. [Pubmed: 11197690].
4. Wolk K., Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 2006, 17(5):367-380. [Pubmed: 17030002].
5. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009, 10(8):857-863. [Pubmed: 19578369].
6. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006, 203(10):2271-2279. [Pubmed: 16982811].
7. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009, 10(8):864-871. [Pubmed: 19578368].
8. Ghoreschi K., Laurence A., Yang X.P., Tato C.M., McGeachy M.J., Konkel J.E., et al. Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling. Nature 2010, 467(7318):967-971. [Pubmed: 2096284].
9. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28(1):29-39. [Pubmed: 18164222].
10. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453(7191):106-109. [Pubmed: 18362914].
11. Eyerich S., Eyerich K., Pennino D., Carbone T., Nasorri F., Pallotta S., et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 2009, 119(12):3573-3585. [Pubmed: 19920355].
12. Hamada H., Garcia-Hernandez Mde L., Reome J.B., Misra S.K., Strutt T.M., Mckinstry K.K., et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 2009, 186(6):3469-3481. [Pubmed:19265125].
13. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330. [Pubmed: 19682928].
14. Simonian P.L., Wehrmann F., Roark C.L., Born W.K., O'Brien R.L., Fontenot A.P. γδ T cells protect against lung fibrosis via IL-22. J Exp Med 2010, 207(10):2239-2253. [Pubmed: 20855496].
15. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457(7230):722-725. [Pubmed: 18978771].
16. + cell populations in gut and skin. Nat Immunol 2009, 10(1):75-82. [Pubmed: 19029904].
17. + cells that provide innate mucosal immune defense. Immunity 2008, 29(6):958-970. [Pubmed:].
18. Marchesi F., Martin A.P., Thirunarayanan N., Devany E., Mayer L., Grisotto M.G., et al. CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol 2009, 2(6):486-494. [Pubmed: 19084435].
19. + cells. Nat Immunol 2009, 10(1):83-91. [Pubmed: 19029903].
20. Satoh-Takayama N., Dumoutier L., Lesjean-Pottier S., Ribeiro V.S., Mandelboim O., Renauld J.C., et al. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol 2009, 183(10):6579-6587. [Pubmed: 19846871].
21. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464(7293):1371-1375. [Pubmed: 20393462].
22. Tachiiri A., Imamura R., Wang Y., Fukui M., Umemura M., Suda T. Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun 2003, 4(2):153-159. [Pubmed: 12618864].
23. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21(2):241-254. [Pubmed: 15308104].
24. Wolk K., Haugen H.S., Xu W., Witte E., Waggie K., Anderson M., et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not. J Mol Med (Berl) 2009, 87(5):523-536. [Pubmed: 19330474].
25. Xu W., Presnell S.R., Parrish-Novak J., Kindsvogel W., Jaspers S., Chen Z., et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci U S A 2001, 9511-9516. [Pubmed: 11481447].
26. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A.K., et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008, 118(2):534-544. [Pubmed: 18172556].
27. Wilson M.S., Feng C.G., Barber D.L., Yarovinsky F., Cheever A.W., Sher A., et al. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 2010, 184(8):4378-4390. [Pubmed: 20220096].
28. Sonnenberg G.F., Fouser L.A., Artis D. Functional biology of the IL-22-IL-22R pathway in regulating immunity and inflammation at barrier surfaces. Adv Immunol 2010, 107:1-29. [Pubmed: 21034969].
29. Pickert G., Neufert C., Leppkes M., Zheng Y., Wittkopf N., Warntjen M., et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009, 206(7):1465-1472. [Pubmed: 19564350].
30. Sonnenberg Gregory F., Fouser Lynette A., Artis David Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011, 12(5):383-390.
31. Kreymborg K., Etzensperger R., Dumoutier L., Haak S., Rebollo A., Buch T., et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J Immunol 2007, 179(12):8098-8104. [Pubmed: 18056351].
32. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., Flavell R.A. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007, 27(4):647-659. [Pubmed: 17919941].
33. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29(6):947-957. [Pubmed: 17719259].
34. Hanash A.M., Dudakov J.A., Hua G., O'Connor M.H., Young L.F., Singer N.V., et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 2012, 37(2):339-350. [Pubmed: 22921121].
35. Couturier M., Lamarthée B., Arbez J., Renauld J.C., Bossard C., Malard F., et al. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect. Leukemia 2013, 27(7):1527-1537. [Pubmed: 23399894].
36. + regulatory T cells. Blood 2011, 118(8):2342-2350. [Pubmed: 21734238].
37. + Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome. J Mol Cell Biol 2012, 4:409-419. [Pubmed: 22773728].
38. Geboes L., Dumoutier L., Kelchtermans H., Schurgers E., Mitera T., Renauld J.C., et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009, 60(2):390-395. [Pubmed: 19180498].
39. Van Belle A.B., de Heusch M., Lemaire M.M., Hendrickx E., Warnier G., Dunussi-Joannopoulos K., et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 2012, 188(1):462-469. [Pubmed: 22131335].
40. Wolk K., Witte E., Wallace E., Döcke W.D., Kunz S., Asadullah K., et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006, 36(5):1309-1323. [Pubmed: 16619290].
41. Sabat R., Wolk K. Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis. J Dtsch Dermatol Ges 2011, 9(7):518-523. [Pubmed: 21251229].
42. Eyerich S., Wagener J., Wenzel V., Scarponi C., Pennino D., Albanesi C., et al. IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur J Immunol 2011, 41(7):1894-1901. [Pubmed: 21469124].
43. Ikeuchi H., Kuroiwa T., Hiramatsu N., Kaneko Y., Hiromura K., Ueki K., et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005, 52(4):1037-1046. [Pubmed: 15818686].
44. Kim K.W., Kim H.R., Park J.Y., Park J.S., Oh H.J., Woo Y.J., et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 2012, 64(4):1015-1023. [Pubmed: 22034096].
45. Marijnissen R.J., Koenders M.I., Smeets R.L., Stappers M.H., Nickerson-Nutter C., Joosten L.A., et al. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum 2011, 63(10):2939-2948. [Pubmed: 21618207].
46. Sarkar S., Zhou X., Justa S., Bommireddy S.R. Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. Arthritis Rheum 2013, 65(4):960-971. [Pubmed: 23334981].
47. Schulz S.M., Köhler G., Schütze N., Knauer J., Straubinger R.K., Chackerian A.A., et al. Protective immunity to systemic infection with attenuated Salmonella enterica serovar Enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17. J Immunol 2008, 181(11):7891-7901. [Pubmed: 19017979].
48. Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009, 123(6):1244-1252. [Pubmed: 19439349].
49. Pennino D., Bhavsar P.K., Effner R., Avitabile S., Venn P., Quaranta M., et al. IL-22 suppresses IFN-r-mediated lung inflammation in asthmatic patients. J Allergy Clin Immunol 2013, 131(2):562-570. [Pubmed:23174657].
50. Schnyder B., Lima C., Schnyder-Candrian S. Interleukin-22 is a negative regulator of the allergic response. Cytokine 2010, 50(2):220-227. [Pubmed: 20194033].
51. Takahashi K., Hirose K., Kawashima S., Niwa Y., Wakashin H., Iwata A., et al. IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J Allergy Clin Immunol 2011, 128(5):1067-1076. [Pubmed: 21794904].